On April 14, IDL participated at Redeye Healthcare Day. CEO Anders Hultman presented the company and shared more about its strategy, current and future markets, and our joint venture with concile. Watch the presentation here
News
Latest news.
CACLP and meeting with new distributor
During CACLP in Xiamen, China’s largest IVD exhibition, IDL Diagnostics had the opportunity to meet a wide range of industry players, exchange valuable insights, and further explore the fast-evolving Chinese IVD market. The trip concluded in Tianjin with our first...
Partnership Meetings and CLIA Focus in China
Anders Hultman, Gustav Sten, Xia Jiang and Marie Torstensson have been in Shanghai, China, to meet our partners within CLIA. Currently, we have one product on the market, TPS CLIA, as well as two products in development: TK1 CLIA and UBC CLIA. The purpose of the...
IDL Diagnostics at EAU26
IDL Diagnostics attended the European Association of Urology (EAU) 2026 conference in London last week. We had valuable discussions with physicians who use our diagnostic biomarkers in clinical practice and research. A big thank you to everyone we met at EAU26! We...
Presentation of IDL Diagnostics Interim Report Q4 2025
CEO Anders Hultman and CFO Ellen Dittberner present the company’s Q4’25 results – February 26, 2026 Q4 Interview: Redeye talks with CEO Anders Hultman
IDL Diagnostics and concile at WHX Labs Dubai
Last week, IDL Diagnostics participated as an exhibitor at WHX Labs Dubai together with concile as part of the recently announced joint venture. The main focus is on delivering multiple biomarkers across different POC reader configurations and supporting infection,...
Meet us at WHX Labs Dubai 10-13 February
We will be co-exhibiting together with our partner concile at Booth SA.A55. Come by our booth and learn more about our products and how quantitative point-of-care testing can be used to provide accurate and rapid results.
IDL Diagnostics participates at RedEye Theme Event Fight Cancer
On January 21st Redeye hosted a Fight Cancer 2026 theme event where CEO Anders Hultman presented about the company, market opportunities and the new strategic priority. See the presentation here
Strategy update: IDL Diagnostics
A strategy update with IDL Diagnostics was held on November 27th at Redeye, where CEO Anders Hultman and the management team presented recent achievements, spotlighted key initiatives, and discussed future opportunities looking toward 2026 and beyond. After their...
Meet us at Medica 17-20 November
IDL Diagnostics will be exhibiting on of the largest medical trade fairs in the works, Medica Dusseldorf starting November 17-20. Visit Gustav Sten, Xia Jiang and Anders Hultman at Hall1, Booth H69








